Literature DB >> 3177265

Pepsinogens and other serum markers in pernicious anemia.

R Carmel1.   

Abstract

Pepsinogen (PG) I and PG II levels were determined in sera from 147 patients with pernicious anemia. Race, sex, age, gastrin level, and antibody status did not influence pepsinogen levels. PG I values less than 30 micrograms/L were found in 92% of cases and PG I to PG II ratios less than 3.0 in 82% of cases. At least one of these two results was abnormal in 97% of all patients with pernicious anemia. In comparison, results of other blood tests used in the investigation of pernicious anemia were less often abnormal. Serum gastrin level exceeded 200 ng/L in 90% of patients with pernicious anemia and was second to pepsinogen abnormality in diagnostic sensitivity. Results for anti-intrinsic factor antibody were positive in 73% of cases and anti-parietal cell antibody in only 52%. Although its specificity is limited, the presence of low PG I level and/or low PG I-PG II ratio is currently the most sensitive serum indicator for pernicious anemia, and absence of both can be taken as a strong argument against the diagnosis. This highly sensitive test can be combined further with the highly specific serum anti-intrinsic factor antibody test for the presumptive diagnosis of pernicious anemia when definitive tests (the Schilling test or gastric analysis for intrinsic factor) cannot be done or results are inconclusive.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177265     DOI: 10.1093/ajcp/90.4.442

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study.

Authors:  N Alonso; M L Granada; B Soldevila; I Salinas; C Joaquin; J L Reverter; J Juncà; E M Martínez Cáceres; A Sanmartí
Journal:  J Endocrinol Invest       Date:  2010-06-04       Impact factor: 4.256

2.  How I treat cobalamin (vitamin B12) deficiency.

Authors:  Ralph Carmel
Journal:  Blood       Date:  2008-07-07       Impact factor: 22.113

Review 3.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

4.  Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race.

Authors:  R Carmel
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

5.  Statistical analysis of serum pepsinogen I (PG I) and II (PG II) levels, PG I/PG II ratios and serum gastrin levels in a general population.

Authors:  A Kazuo; M Junichi
Journal:  Environ Health Prev Med       Date:  1996-10       Impact factor: 3.674

6.  Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability.

Authors:  Deanne L V Greenwood; Patricia Crock; Stephen Braye; Patricia Davidson; John W Sentry
Journal:  Eur J Pediatr       Date:  2008-01-24       Impact factor: 3.183

Review 7.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

8.  Magnesium hydrogen breath test using end expiratory sampling to assess achlorhydria in pernicious anaemia patients.

Authors:  P Humbert; P López de Soria; F Fernández-Bañares; J Juncá; J Boix; R Planas; J C Quer; E Domenech; M A Gassull
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 9.  Chronic hypergastrinemia: causes and consequences.

Authors:  Lori A Orlando; Lane Lenard; Roy C Orlando
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

10.  A multicenter retrospective analysis of the clinical features of pernicious anemia in a Korean population.

Authors:  Ik-Chan Song; Hyo Jin Lee; Han-Jo Kim; Sang-Byung Bae; Kyu-Taek Lee; Young-Jun Yang; Suk-Young Park; Do-Yeun Cho; Nae Yu Kim; In-Sung Cho; Deog-Yeon Jo
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.